ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2020 and some content may be unavailable. To unlock all content for 2020, please visit the archives.

Abstract: PO1446

Serum Potassium Levels at Hospital Discharge and 1-Year Mortality Among Hospitalized Patients

Session Information

Category: Fluid, Electrolyte, and Acid-Base Disorders

  • 902 Fluid, Electrolyte, and Acid-Base Disorders: Clinical

Authors

  • Mao, Michael A., Mayo Clinic's Campus in Florida, Jacksonville, Florida, United States
  • Thongprayoon, Charat, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Cheungpasitporn, Wisit, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Thirunavukkarasu, Sorkko, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Chewcharat, Api, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Erickson, Stephen B., Mayo Clinic Minnesota, Rochester, Minnesota, United States
Background

The aim was to assess the relationship between discharge serum potassium levels and one-year mortality in hospitalized patients.

Methods

All adult hospital survivors between years 2011 and 2013 at a tertiary referral hospital who had available admission and discharge serum potassium levels were enrolled. End-stage kidney disease patients were excluded. Discharge potassium was defined as the last potassium measured within 48 hours prior to hospital discharge and categorized into ≤2.9, 3.0-3.4, 3.5-3.9, 4.0-4.4, 4.5-4.9, 5.0-5.4 and ≥5.5 mEq/L. Cox proportional hazard analysis was performed to assess the independent association between discharge potassium and one-year mortality after hospital discharge, using discharge potassium of 4.0-4.4 mEq/L as the reference group.

Results

Of 57,874 eligible patients, with a mean discharge serum potassium of 4.1±0.4 mEq/L, the estimated one-year mortality rate after discharge was 13.2%. A U-shaped association was observed between discharge potassium and one-year mortality, with nadir mortality in the discharge potassium of 4.0-4.4 mEq/L. After adjustment for clinical characteristics, including admission potassium, both discharge potassium of ≤3.9 mEq/L and ≥4.5 mEq/L were significantly associated with increased one-year mortality, compared with the discharge potassium of 4.0-4.4 mEq/L. Stratified analysis based on admission serum potassium showed similar results except that there was no increased risk of one-year mortality if discharge potassium group was ≤3.9 mEq/L in patients with an admission potassium of ≥5.0 mEq/L.

Conclusion

The association between discharge serum potassium and one-year mortality after hospital discharge had a U-shaped distribution and was independent of admission potassium. Favorable survival outcomes occurred when discharge potassium was within the range of 4.0-4.4 mEq/L.

The Kaplan-Meier plot of one-year mortality based on discharge serum potassium levels